A Centers for Disease Control and Prevention (CDC) committee did not hold a vote regarding guidance on Johnson & Johnson’s COVID-19 vaccine Wednesday after federal …
A Centers for Disease Control and Prevention (CDC) committee did not hold a vote regarding guidance on Johnson & Johnson’s COVID-19 vaccine Wednesday after federal officials recommended a pause in the rollout. The Advisory Committee on Immunization Practices (ACIP) met one day after the FDA and CDC recommended the pause over concern of six instances of a rare, severe blood clot in over 6.8 million vaccine recipients.
